| NDC Number | Brand Name | Generic Name | Manufacturer | Dosage Form | DEA Sch. | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0069-0809 | INFLECTRA | infliximab-dyyb | Pfizer Laboratories Div Pfizer Inc | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2016-11-21 | |
| 50090-6704 | HADLIMA | adalimumab-bwwd | A-S Medication Solutions | SOLUTION | 2023-07-01 | |
| 50090-6705 | HADLIMA | adalimumab-bwwd | A-S Medication Solutions | SOLUTION | 2023-07-01 | |
| 50090-6706 | HADLIMA | adalimumab-bwwd | A-S Medication Solutions | SOLUTION | 2023-07-01 | |
| 50090-6707 | HADLIMA | adalimumab-bwwd | A-S Medication Solutions | SOLUTION | 2023-07-01 | |
| 50474-700 | Cimzia | certolizumab pegol | UCB, Inc. | KIT | 2008-04-20 | |
| 50474-710 | Cimzia | certolizumab pegol | UCB, Inc. | INJECTION, SOLUTION | 2009-05-14 | |
| 50474-750 | Cimzia | certolizumab pegol | UCB, Inc. | INJECTION, SOLUTION | 2025-03-01 | |
| 55513-399 | AMJEVITA | adalimumab-atto | Amgen Inc | INJECTION | 2023-08-14 | |
| 55513-400 | AMJEVITA | adalimumab-atto | Amgen Inc | INJECTION | 2023-01-31 | |
| 55513-410 | AMJEVITA | adalimumab-atto | Amgen Inc | INJECTION | 2023-01-31 | |
| 55513-411 | AMJEVITA | adalimumab-atto | Amgen Inc | INJECTION | 2023-01-31 | |
| 55513-413 | AMJEVITA | adalimumab-atto | Amgen Inc | INJECTION | 2023-04-06 | |
| 55513-479 | AMJEVITA | adalimumab-atto | Amgen Inc | INJECTION | 2023-08-14 | |
| 55513-480 | AMJEVITA | adalimumab-atto | Amgen Inc | INJECTION | 2023-08-14 | |
| 55513-481 | AMJEVITA | adalimumab-atto | Amgen Inc | INJECTION | 2023-08-14 | |
| 55513-482 | AMJEVITA | adalimumab-atto | Amgen Inc | INJECTION | 2023-08-14 | |
| 55513-670 | AVSOLA | infliximab-axxq | Amgen, Inc | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2019-12-12 | |
| 57894-030 | REMICADE | INFLIXIMAB | Janssen Biotech, Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 1998-08-24 | |
| 57894-070 | Simponi | golimumab | Janssen Biotech, Inc. | INJECTION, SOLUTION | 2009-04-25 | |
| 57894-071 | Simponi | golimumab | Janssen Biotech, Inc. | INJECTION, SOLUTION | 2013-05-15 | |
| 57894-160 | INFLIXIMAB | INFLIXIMAB | Janssen Biotech, Inc. | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2021-10-05 | |
| 57894-350 | SIMPONI ARIA | golimumab | Janssen Biotech, Inc. | SOLUTION | 2013-07-19 | |
| 58406-010 | ENBREL | etanercept | Immunex Corporation | SOLUTION | 2019-06-07 | |
| 58406-021 | ENBREL | etanercept | Immunex Corporation | SOLUTION | 2019-06-07 | |
| 58406-032 | ENBREL | etanercept | Immunex Corporation | SOLUTION | 2019-06-07 | |
| 58406-044 | ENBREL | etanercept | Immunex Corporation | SOLUTION | 2019-06-07 | |
| 58406-055 | ENBREL | etanercept | Immunex Corporation | SOLUTION | 2020-03-05 | |
| 61314-325 | Adalimumab | adalimumab-adaz | Sandoz Inc | INJECTION, SOLUTION | 2025-01-06 | |
| 61314-327 | Adalimumab | adalimumab-adaz | Sandoz Inc | INJECTION, SOLUTION | 2023-07-01 | |
| 61314-332 | Adalimumab | adalimumab-adaz | Sandoz Inc | INJECTION, SOLUTION | 2024-12-02 | |
| 61314-391 | Adalimumab | adalimumab-adaz | Sandoz Inc | INJECTION, SOLUTION | 2025-03-26 | |
| 61314-454 | HYRIMOZ | adalimumab-adaz | Sandoz Inc | INJECTION, SOLUTION | 2023-07-01 | |
| 61314-473 | HYRIMOZ | adalimumab-adaz | Sandoz Inc | INJECTION, SOLUTION | 2023-07-01 | |
| 61314-476 | HYRIMOZ | adalimumab-adaz | Sandoz Inc | INJECTION, SOLUTION | 2023-07-01 | |
| 61314-509 | HYRIMOZ | adalimumab-adaz | Sandoz Inc | INJECTION, SOLUTION | 2023-07-01 | |
| 61314-517 | HYRIMOZ | adalimumab-adaz | Sandoz Inc | KIT | 2023-07-01 | |
| 61314-531 | HYRIMOZ | adalimumab-adaz | Sandoz Inc | KIT | 2023-07-01 | |
| 70114-210 | YUSIMRY | adalimumab-aqvh | Coherus BioSciences Inc | INJECTION, SOLUTION | 2023-07-01 | |
| 70114-220 | YUSIMRY | adalimumab-aqvh | Coherus BioSciences Inc | INJECTION, SOLUTION | 2023-07-01 | |
| 71288-815 | YUSIMRY | adalimumab-aqvh | Meitheal Pharmaceuticals Inc. | INJECTION, SOLUTION | 2023-07-01 | |
| 71288-816 | YUSIMRY | adalimumab-aqvh | Meitheal Pharmaceuticals Inc. | INJECTION, SOLUTION | 2023-07-01 | |
| 72511-399 | AMJEVITA | adalimumab-atto | Amgen USA Inc. | INJECTION | 2024-11-08 | |
| 72511-400 | AMJEVITA | adalimumab-atto | Amgen USA Inc. | INJECTION | 2023-01-31 | |
| 72511-479 | AMJEVITA | adalimumab-atto | Amgen USA Inc. | INJECTION | 2024-11-08 | |
| 72511-481 | AMJEVITA | adalimumab-atto | Amgen USA Inc. | INJECTION | 2023-08-14 | |
| 72511-482 | AMJEVITA | adalimumab-atto | Amgen USA Inc. | INJECTION | 2023-08-14 | |
| 78206-162 | Renflexis | infliximab | Organon LLC | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 2017-04-21 | |
| 78206-183 | Hadlima | adalimumab-bwwd | Organon LLC | SOLUTION | 2023-07-01 | |
| 78206-184 | Hadlima | adalimumab-bwwd | Organon LLC | SOLUTION | 2023-07-01 | |
| 78206-185 | Hadlima | adalimumab-bwwd | Organon LLC | SOLUTION | 2023-07-01 | |
| 78206-186 | Hadlima | adalimumab-bwwd | Organon LLC | SOLUTION | 2023-07-01 | |
| 78206-187 | Hadlima | adalimumab-bwwd | Organon LLC | SOLUTION | 2023-07-01 | |
| 78206-203 | Adalimumab-bwwd | adalimumab-bwwd | Organon LLC | SOLUTION | 2023-06-30 | |
| 78206-204 | Adalimumab-bwwd | adalimumab-bwwd | Organon LLC | SOLUTION | 2023-06-30 | |
| 78206-205 | Adalimumab-bwwd | adalimumab-bwwd | Organon LLC | SOLUTION | 2023-06-30 | |
| 78206-206 | Adalimumab-bwwd | adalimumab-bwwd | Organon LLC | SOLUTION | 2023-06-30 | |
| 78206-207 | Adalimumab-bwwd | adalimumab-bwwd | Organon LLC | SOLUTION | 2023-06-30 | |
| 83457-100 | HYRIMOZ | adalimumab-adaz | Cordavis Limited | INJECTION, SOLUTION | 2023-09-21 | |
| 83457-101 | HYRIMOZ | adalimumab-adaz | Cordavis Limited | INJECTION, SOLUTION | 2023-09-21 | |
| 83457-102 | HYRIMOZ | adalimumab-adaz | Cordavis Limited | INJECTION, SOLUTION | 2023-09-21 | |
| 83457-103 | HYRIMOZ | adalimumab-adaz | Cordavis Limited | INJECTION, SOLUTION | 2023-09-21 | |
| 83457-107 | HYRIMOZ | adalimumab-adaz | Cordavis Limited | INJECTION, SOLUTION | 2023-12-15 | |
| 83457-108 | HYRIMOZ | adalimumab-adaz | Cordavis Limited | INJECTION, SOLUTION | 2023-12-15 | |
| 83457-112 | HYRIMOZ | adalimumab-adaz | Cordavis Limited | KIT | 2023-12-15 | |
| 83457-113 | HYRIMOZ | adalimumab-adaz | Cordavis Limited | INJECTION, SOLUTION | 2023-12-15 | |
| 84612-399 | AMJEVITA | adalimumab-atto | Optum Health Solutions (Ireland) Limited | INJECTION | 2025-01-01 | |
| 84612-479 | AMJEVITA | adalimumab-atto | Optum Health Solutions (Ireland) Limited | INJECTION | 2025-01-01 | |
| 84612-481 | AMJEVITA | adalimumab-atto | Optum Health Solutions (Ireland) Limited | INJECTION | 2025-01-01 | |
| 84612-482 | AMJEVITA | adalimumab-atto | Optum Health Solutions (Ireland) Limited | INJECTION | 2025-01-01 |
Loading full table content...